These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6617438)

  • 21. Measles vaccine failures.
    Christopher PJ
    Med J Aust; 1988 Jan; 148(2):103. PubMed ID: 3336319
    [No Abstract]   [Full Text] [Related]  

  • 22. Measles vaccine efficacy in India: a review.
    Singh J; Datta KK
    J Commun Dis; 1997 Mar; 29(1):47-56. PubMed ID: 9282529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Shane Pankratz V; Jacobsen SJ; Poland GA
    Vaccine; 2004 May; 22(15-16):1914-20. PubMed ID: 15121303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to the control of measles by vaccination in the People's Republic of China.
    Zhiang Y; Su W
    Rev Infect Dis; 1983; 5(3):568-73. PubMed ID: 6879016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles and measles vaccine isolated amerindian tribes. I. The 1971 Trio ((Tiriyo) epidemic.
    van Mazijk J; Pinheiro FP; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):3-6. PubMed ID: 7080183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroconversion rates and measles antibody titers induced by measles vaccine in Latin American children 6-12 months of age. Collaborative Study by the Ministries of Health of Brazil, Chile, Costa Rica, Ecuador, and the Pan American Health Organization.
    Bull Pan Am Health Organ; 1982; 16(3):272-85. PubMed ID: 7171892
    [No Abstract]   [Full Text] [Related]  

  • 30. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune response to various antiviral vaccines].
    Tabin R; Berclaz JP; Dupuis G; Peter O
    Rev Med Suisse Romande; 1993 Dec; 113(12):981-4. PubMed ID: 8290849
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and safety of Abhay M and M-vac vaccines in healthy infants: a phase III multicentric randomized single blind trial.
    Zodpey SP; Agarkhedkar SR; Reddy GA; Rao MI; Shenoy UV; Murthy SR; Maiya PP
    Indian J Public Health; 2008; 52(1):5-10. PubMed ID: 18700714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of measles vaccination on the progression of atopic dermatitis in infants.
    Hennino A; Cornu C; Rozieres A; Augey F; Villard-Truc F; Payot F; Lachaux A; Nicolas JF; Horvat B
    Pediatr Allergy Immunol; 2007 Aug; 18(5):385-90. PubMed ID: 17617807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical reactogenicity and immunogenicity of five live measles vaccine strains.
    Chin Med J (Engl); 1981 Apr; 94(4):201-6. PubMed ID: 6790234
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.
    Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH
    Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
    al-Attar I; Reisman J; Muehlmann M; McIntosh K
    Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.